CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Questionnaires, spirometryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (0)

Name (Synonyms) Correlation

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Recovery in Patients With SARS-CoV-2 Associated Respiratory Failure

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the current pandemic of coronavirus disease (COVID-19) that can lead to respiratory failure requiring oxygen therapy. Some patients develop acute respiratory distress syndrome (ARDS) and may die despite intensive care therapy. Currently it is unknown a) how fast patients recover after being discharged from hospital and b) what underlying predictors may influence recovery.

NCT04365595 SARS-CoV 2 COVID Other: Questionnaires, spirometry
MeSH:Respiratory Insufficiency

Primary Outcomes

Description: European Quality of Life - 5 Dimensions - 5 Levels Instrument (EQ-5D-5L). Scoring: Index ranges from 1 to <0, with lower scores indicating more limitations.

Measure: Health-related quality-of-life

Time: 3 months

Secondary Outcomes

Description: Hospital Axiety and Depression Score (HADS). Scoring: Scores range from 0 to 42, with higher scores indicating more anxiety or depression symptoms.

Measure: Anxiety and depression

Time: 3 months

Description: COPD Assessment Test (CAT). Scoring: Scores range from 0-40, with higher scores indicating more symptoms due to respiratory limitations.

Measure: Symptom burden

Time: 3 months

Description: Forced expiratory volume in one second (FEV1) in liters and percent predicted.

Measure: Spirometry

Time: 1 month

Description: Forced vital capacity (FVC) in liters and percent predicted.

Measure: Spirometry

Time: 1 month

No related HPO nodes (Using clinical trials)